Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
06/08/2026 12:01
BRIEF-Ligand Pharmaceuticals Q2 EPS USD 2.22 Aug 06 (Reuters) - Ligand Pharmaceuticals Q2 operating income USD 8.591 million.
- Q2 net income USD 48.508 million
- Q2 pretax profit USD 64.304 million
- Q2 basic EPS USD 2.42
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan